Influenza-induced inflammation drives pneumococcal otitis media

Area of Science:

• Microbiology
• Virology
• Immunology
• Otolaryngology

Background:

• Influenza A virus (IAV) predisposes individuals to secondary infections, notably with Streptococcus pneumoniae.
• The mechanism underlying IAV's potentiation of pneumococcal disease (pneumonia, sepsis, meningitis, otitis media) is debated, with theories including immune dysregulation or immunosuppression.
• Most research focuses on pneumococcal pneumonia, leaving the impact of IAV on other phenotypes like otitis media (OM) unclear.

Purpose of the Study:

• To investigate the mechanisms by which IAV promotes secondary bacterial otitis media (OM).
• To determine the role of viral replication and host inflammatory response in IAV-associated OM.
• To elucidate the specific contribution of the influenza virus hemagglutinin (HA) in disease pathogenesis.

Main Methods:

• Utilized an infant mouse model to study IAV-induced otitis media.
• Employed human middle ear epithelial cells for in vitro analysis.
• Generated a series of reverse-engineered influenza viruses to dissect the function of viral components, particularly HA.

Main Results:

• Influenza virus HA facilitates disease by inducing a replication-dependent proinflammatory response in the middle ear.
• The study identified the inflammatory response to IAV infection as the key mediator of pneumococcal replication in the middle ear.
• Demonstrated that inflammation, rather than immunosuppression, drives bacterial growth in this context.

Conclusions:

• Influenza A virus infection promotes pneumococcal otitis media through a replication-dependent inflammatory response in the middle ear.
• The study provides the first evidence that inflammation directly drives pneumococcal replication in the middle ear cavity.
• Findings suggest that targeting inflammation may be a crucial therapeutic strategy for treating secondary pneumococcal otitis media.